Receptors, Tumor Necrosis Factor, Type II

"Receptors, Tumor Necrosis Factor, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.

Descriptor ID	D047889
MeSH Number(s)	D12.776.543.750.705.852.760.798
Concept/Terms	Receptors, Tumor Necrosis Factor, Type II Receptors, Tumor Necrosis Factor, Type II Receptors, Tumor Necrosis Factor, Member 1B TNF-R2 TNF-R75 TNF-RII TNFR p75 Tumor Necrosis Factor Receptor 75 Tumor Necrosis Factor Receptor 2 TNFR2 Tumor Necrosis Factor Receptor Type 2 Tumor Necrosis Factor Receptor Type II Antigens, CD120b CD120b Antigens TNFRSF1B Receptor Receptor, TNFRSF1B Tumor Necrosis Factor Receptor Superfamily, Member 1B CD 120b Antigen 120b Antigen, CD Antigen, CD 120b CD120b Antigen Antigen, CD120b TNFR p80 TNFR p80 TNF-sR75 TNF-sR75

Below are MeSH descriptors whose meaning is more general than "Receptors, Tumor Necrosis Factor, Type II".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Tumor Necrosis Factor [D12.776.543.750.705.852.760]
Receptors, Tumor Necrosis Factor, Type II [D12.776.543.750.705.852.760.798]

Below are MeSH descriptors whose meaning is related to "Receptors, Tumor Necrosis Factor, Type II".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Tumor Necrosis Factor, Type II".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in this website by year, and whether "Receptors, Tumor Necrosis Factor, Type II" was a major or minor topic of these publications.

Bar chart showing 18 publications over 14 distinct years, with a maximum of 2 publications in 2002 and 2008 and 2012 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1999	0	1	1
2000	0	1	1
2002	0	2	2
2005	0	1	1
2006	0	1	1
2007	0	1	1
2008	1	1	2
2012	1	1	2
2015	0	1	1
2016	0	1	1
2017	0	1	1
2018	1	0	1
2019	1	1	2

Below are the most recent publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in Profiles.

Garudadri S, Woodruff PG, Han MK, Curtis JL, Barr RG, Bleecker ER, Bowler RP, Comellas A, Cooper CB, Criner G, Dransfield MT, Hansel NN, Paine R, Krishnan JA, Peters SP, Hastie AT, Martinez FJ, O'Neal WK, Couper DJ, Alexis NE, Christenson SA. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved?Spirometry in SPIROMICS. Chest. 2019 05; 155(5):908-917.

View in: PubMed
Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, Hankinson SE, Rosner BA, Whitcomb BW. A prospective study of inflammatory biomarker levels and risk of early menopause. Menopause. 2019 01; 26(1):32-38.

View in: PubMed
Mansouri S, Patel S, Katikaneni DS, Blaauboer SM, Wang W, Schattgen S, Fitzgerald K, Jin L. Immature lung TNFR2- conventional DC 2 subpopulation activates moDCs to promote cyclic di-GMP mucosal adjuvant responses in vivo. Mucosal Immunol. 2019 01; 12(1):277-289.

View in: PubMed
Li W, Dorans KS, Wilker EH, Rice MB, Ljungman PL, Schwartz JD, Coull BA, Koutrakis P, Gold DR, Keaney JF, Vasan RS, Benjamin EJ, Mittleman MA. Short-Term Exposure to Ambient Air Pollution and Biomarkers of Systemic Inflammation: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2017 09; 37(9):1793-1800.

View in: PubMed
Ra SW, Sze MA, Lee EC, Tam S, Oh Y, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Sin DD. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respir Res. 2017 05 30; 18(1):109.

View in: PubMed
Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA, Blander JM, Ting AT. CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. Cell Rep. 2016 06 14; 15(11):2449-61.

View in: PubMed
Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park HL, Rosal MC, Shikany JM, Shivappa N, Ockene JK, Hebert JR. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015 Jun; 25(6):398-405.

View in: PubMed
Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, Levy D, Keaney JF, Wang TJ, Murabito JM, Vasan RS, Benjamin EJ. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol. 2013 Jul; 33(7):1728-33.

View in: PubMed
Fontes JD, Yamamoto JF, Larson MG, Wang N, Dallmeier D, Rienstra M, Schnabel RB, Vasan RS, Keaney JF, Benjamin EJ. Clinical correlates of change in inflammatory biomarkers: The?Framingham Heart Study. Atherosclerosis. 2013 May; 228(1):217-23.

View in: PubMed
Bertone-Johnson ER, Whitcomb BW, Missmer SA, Karlson EW, Rich-Edwards JW. Inflammation and early-life abuse in women. Am J Prev Med. 2012 Dec; 43(6):611-20.

View in: PubMed

People

Explore

Similar Concepts

Top Journals